e Nocardiosis is a rare disease that is caused by Gram-positive actinobacteria of the Nocardia genus and affects predominantly immunocompromised patients. In its disseminated form, it has a predilection for the central nervous system and is associated with high mortality rates. Therefore, prompt identification of the pathogen is critical. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry is a relatively novel technique used for identification of microorganisms. In this work, an upgraded MALDI-TOF Biotyper database containing Corynebacterineae representatives of strains deposited in the Polish Collection of Microorganisms was created and used for identification of the strain isolated from a nocardial brain abscess, mimicking a brain tumor, in an immunocompetent patient. Testing with the API Coryne system initially incorrectly identified Rhodococcus sp., while chemotaxonomic tests, especially mycolic acid analysis, enabled correct Nocardia identification only at the genus level. Subsequent sequence analysis of 16S rRNA and secA1 genes confirmed the identification. To improve the accuracy of the results, an in-house database was constructed using optimized parameters; with the use of the database, the strain was eventually identified as Nocardia farcinica. Clinical laboratories processing various clinical strains can upgrade a commercial database to improve and to accelerate the results obtained. This is especially important in the case of Nocardia, for which valid microbial diagnosis remains challenging; reference laboratories are often required to identify and to survey these rare actinobacteria.
the strain isolated from a nocardial brain abscess mimicking a brain tumor in an immunocompetent patient with no underlying risk factors.
MATERIALS AND METHODS
Bacterial strains. Strains belonging to the Corynebacterineae suborder that were used for creation of the in-house MALDI database were obtained from the Polish Collection of Microorganisms (PCM) at the Institute of Immunology and Experimental Therapy (Wrocław, Poland) (see Table S1 in the supplemental material). The clinical strain R679, which was isolated from the brain abscess (see below), was also studied.
The actinobacterial strains were cultivated on solid media, i.e., glucose-yeast extract agar (medium 79) (6) , nutrient agar, brain heart infusion (BHI) agar, and blood agar, at 37°C for 24 h to 48 h. The Mycobacterium spp. were cultivated on Lowenstein-Jensen agar slants at 37°C for 2 to 14 days, depending on the strain. For determination of the optimal time of cultivation, actinobacterial strains were incubated at 37°C for 24 h to 14 days.
Sample preparation for MALDI-TOF MS. For a direct transfer method, material from a fresh 24-h or 48-h colony was picked up with a toothpick, smeared on an MTP 384 polished steel target plate, coated with a matrix solution of ␣-cyano-4-hydroxycinnamic acid (HCCA) in 50% acetonitrile with 2.5% trifluoroacetic acid (TFA), and dried at room temperature.
For the protein extraction method, the standard procedure recommended by the manufacturer (M1) was used, with some modifications. The procedure was as follows. One loop of bacterial mass (approximately 10 l) was suspended in 300 l of Milli-Q water using a micropestle, and the suspension was vortex-mixed for 30 s. Next, 900 l of pure ethanol was added, and the suspension was mixed for 1 min using a vortex mixer. The cell suspension was centrifuged with a Sigma 1-15K centrifuge at 13,000 rpm for 2 min, the supernatant was discarded, and then the pellet was centrifuged again to remove the remaining ethanol. The pellet was dried in a laminar cabinet and resuspended in 70% formic acid (5 to 50 l) with thorough mixing, and then acetonitrile in the same volume as formic acid was added. After centrifugation (13,000 rpm for 2 min), 1 l of protein extract was applied to a steel target, dried at room temperature, and coated with 1 l of matrix solution (HCCA). The following procedure modifications were applied: use of 0.1-mm zirconia/silica beads (Carl Roth, Karlsruhe, Germany) to aid extraction with formic acid, according to the report by Saleeb et al. (7) (modification M2), heating of the bacterial mass at 100°C for 30 min in a water bath (modification M3), and both heating and zirconia/silica beads as additions to the standard procedure (modification M4). The modified procedure with Tween 20 described by El Khéchine et al. (8) was also utilized (modification M5). A chart depicting the extraction methods is presented in Fig. S1 in the supplemental material.
MALDI-TOF MS analysis. All analyses were performed with an Autoflex III mass spectrometer (Bruker Daltonics, Germany) using the Biotyper 3.0 software and database, containing 4,613 entries. The clinical strain R679 was also analyzed with an Ultraflex system (Bruker Daltonics, Germany), using the same software and database. Before each measurement, calibration of the mass spectrometer with Bruker Bacterial Test Standard was performed according to the manufacturer's recommendations. Spectra were recorded in the linear positive mode at a laser frequency of 200 Hz, in a mass range of 2,000 to 20,000 Da. The sum spectra of 1,000 laser shots were acquired in portions of 200 laser shots from 5 different spot positions with 40% laser intensity. To generate the in-house database, 12 raw spectra of good quality were chosen and transferred to the peak list by the Biotyper 3.0 software. Identification criteria used in the analysis, formulated by the manufacturer, were as follows: score value below 1.699, identification unreliable; score value of 1.700 to 1.999, probable genus identification; score value of 2.000 to 2.299, reliable genus identification, probable species identification; score value of 2.300 to 3.000, highly probable species identification.
Optimal conditions for creation of in-house MALDI-TOF MS database. In order to improve the quality of MS spectra, different cultivation media and times of cultivation were evaluated. The effects of modifications of the extraction procedure were also analyzed. The species used in these analyses were Corynebacterium glutamicum PCM 1945, Gordonia terrae PCM 2591, Nocardia nova PCM 2607 T , Rhodococcus rhodochrous PCM 2452
T , Tsukamurella paurometabola PCM 2453 T , and Mycobacterium smegmatis PCM 659.
Identification of clinical strain R679 isolated from brain abscess. (i) Biochemical identification. Biochemical testing of the clinical strain R679 was performed using commercially available API Coryne test strips (bioMérieux) for manual identification. The API Coryne test strip system contains 20 dehydrated substrates for enzymes such as pyrazinamidase, pyrrolidonyl arylamidase, ␤-galactosidase, alkaline phosphatase, ␣-glucosidase, N-acetylglucosaminidase, and ␤-glucuronidase. It also allows for testing of nitrate reduction, gelatin, urea, and esculin hydrolysis, and carbohydrate (glucose, ribose, D-xylose, mannitol, maltose, lactose, sucrose, and glycogen) fermentation. The test was set up according to the manufacturer's instructions, and samples were incubated at 36°C for 24 h. Catalase activity was determined by adding a drop of hydrogen peroxide (3%) to isolated colonies.
(ii) Antimicrobial susceptibility testing. Susceptibility to amikacin, ceftriaxone, clarithromycin, minocycline, trimethoprim-sulfamethoxazole (TMP-SMX), imipenem, amoxicillin-clavulanate, moxifloxacin, ciprofloxacin, and linezolid was assessed by the broth microdilution method, according to the current CLSI recommendations (9) . Susceptibility testing was performed by the Special Bacteriology Reference Laboratory (SBRL) of the Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention (Atlanta, GA).
(iii) Chemotaxonomic identification. Sugars and the diaminopimelic acid (DAP) isomers of peptidoglycan in a whole-cell hydrolysate of the clinical isolate were detected according to the method described by Lechevalier and Lechevalier (10) and N-glycolylated muramic acid by the colorimetric method (11) . Phospholipid and glycolipid profiles were determined by thin-layer chromatography (TLC) (12) . The fatty acid methyl esters were determined by gas-liquid chromatography (GLC)-MS and mycolic acids by TLC (13) . Purified mycolic acid methyl esters from clinical isolate R679, Nocardia asteroides, and Nocardia farcinica were analyzed with an Ultraflex MALDI-TOF MS system (Bruker Daltonics, Germany), using 2,5-dihydroxybenzoic acid as a matrix, in reflectron positive-ion mode.
(iv) 16S rRNA and secA1 gene sequencing. Chromosomal DNA was isolated from the clinical strain (14) , and the 16S rRNA gene was amplified in three independent PCRs using specific primers (15) ; the PCR products obtained were cloned using the pGem-T Easy vector system and subsequently sequenced (16) . Identification of the phylogenetic neighbors was initially carried out by BLASTN program matching against a database containing type strains with validly published prokaryotic names and representatives of uncultured phylotypes, i.e., the EzTaxon-e database (17) . The top 30 sequences with the highest scores were then selected for the calculation of pairwise sequence similarity using a global alignment algorithm, which was implemented on the EzTaxon-e server. The secA1 gene sequence was obtained using the following modified primers: secA1_F, 5=-GACAGYGAGTGGATGGGYCGSGTGCACCG-3=; secA1_R, 5=-GC GGACGATGTAGTCCTTGTC-3= (18); products of three independent PCRs were sequenced. The phylogeny of the 16S and secA1 genes was analyzed as described by Pasciak et al. (19) , using MEGA6 software (20) .
Nucleotide sequence accession numbers. The 16S rRNA and secA1 gene sequences of clinical isolate R679 from a brain abscess were submitted to GenBank under accession numbers KC478309 (1,457 bp) and KP662923 (489 bp), respectively.
RESULTS

Generation of in-house
Corynebacterineae database. (i) Comparison of direct transfer and extraction methods. The first step in setting up the MALDI in-house database was to choose the method for sample preparation, which would be used for the creation of protein fingerprints. One representative strain from each genus was selected and cultivated on glucose-yeast extract agar (medium 79) at 37°C for 48 h. MALDI-TOF mass spectra were obtained for samples prepared by either the direct transfer method or the extraction method (M1), the latter as recommended by the manufacturer. The results obtained with these two sample preparation methods were compared in Fig. 1 . Since the extraction method yielded better mass spectra and higher score values, it was used exclusively in further analyses. In comparison with other Corynebacterineae representatives, especially from the Corynebacterium or Tsukamurella genera, the score values of Nocardia spp. in the MALDI-TOF Biotyper system were always lower, regardless of the method of sample preparation ( Fig. 1) .
(ii) Elaboration of optimal conditions for MALDI-TOF inhouse database construction. Depending on the culture medium, small differences in the mass spectra obtained were seen. For Corynebacterium, Rhodococcus, and Tsukamurella genera, the best media were glucose-yeast extract agar (medium 79) and blood agar, while BHI medium was the worst (see Table S2 in the supplemental material). For construction of the database, two kinds of solid media were selected according to the results obtained for the genus ( Table 1 ). The M2 modification of the extraction procedure, i.e., the use of zirconia/silica beads for extraction with formic acid, gave the best results in the case of Gordonia and Nocardia representatives (see Table S2 in the supplemental material). Another modification, M5 with Tween 20, proved to be most effective with Mycobacterium spp. (see Table S2 in the supplemental material). Thermal inactivation of the biomass, as used in the M3 and M4 modifications, worsened the score values in all cases.
The next step was to determine the optimal cultivation time for a given medium and extraction method. Satisfactory results were achieved after 2 days of cultivation for N. nova and C. glutamicum, and mass spectra obtained for 14-day incubations are presented in Fig. S2 and S3 in the supplemental material. Most of the Mycobacterium spp. studied belonged to the fast-growing mycobacteria and 72-h incubations were sufficient for their identification, with the exception of Mycobacterium scrofulaceum, for which 10 days of incubation was needed to obtain the necessary yield.
The best parameters determined for the creation of an in- house database are presented in Table 1 . The same optimal conditions were used for all representatives of genera. For the Nocardia genus, the best results were obtained with solid media, i.e., medium 79 (6) and blood agar, with 48 h of incubation and extraction modification M2. The MALDI-TOF mass spectra of the Nocardia strains studied are presented in Fig. 2 .
The construction of an in-house database allowed for a significant increase in the reliability of identification for the majority of tested Nocardia strains. Score values are listed in Table 2 . The summary of identification of Corynebacterineae representatives of PCM species in the Biotyper database, using the optimal parameters determined, is presented in Table S3 in the supplemental material.
Case illustration. A 53-year-old woman presented to the emergency department due to rapidly progressing hemiparesis. Computerized axial tomography (CAT) followed by magnetic resonance imaging (MRI) revealed a relatively large pathological mass (approximately 50 mm in diameter) located in the right temporoparietal region and surrounded by significant edema. With a tentative diagnosis of glioblastoma multiforme, the patient was admitted to the neurosurgical department for surgical treatment. Intraoperatively, the mass was determined to be an abscess. It was evacuated, and a specimen was sent for microbiological examination.
The culturing of pus on 5% sheep blood in tryptic soy agar (TSA) for 24 h yielded rough orange colonies. The API Coryne identification strip (bioMérieux) profile obtained identified the isolate as Rhodococcus with 84.4% probability (identification profile 3151004); the other possible identifications were Gordonia, Dietzia, or Nocardia. T . Colonies grown on glucose-yeast extract agar (medium 79) were incubated at 37°C for 48 h. Spectra were acquired using extraction protocol M2 and HCCA matrix solution.
D-saccharose, and glycogen) were negative. The following empirical antibiotic therapy was introduced: 480 mg of TMP-SMX three times a day, 100 mg of doxycycline once a day, and 500 mg of ciprofloxacin twice a day.
On day 7 after surgery, the patient's condition began to deteriorate and a recurrent abscess was found in a CAT scan. The patient underwent surgical drainage of the newly formed abscess. Intraoperative cultures again revealed Rhodococcus by API Coryne strip identification. After the second operation, the patient initially made a good recovery; after another 3 weeks, however, she presented with a new neurological deficit. The CAT and MRI scans revealed multiple new abscesses, surrounded by marked edema and significant midline shift. The patient underwent another operation, and the microbiological diagnosis was consistent with previous findings. Microbial cultures of blood samples (BD Bactec) incubated for 5 and 10 days under aerobic and anaerobic conditions yielded negative results. Eventually the patient was discharged with an order for oral TMP-SMX (480 mg) treatment twice a day for a prolonged period. Her neurological deficit eventually improved significantly, and imaging studies were negative for recurrence.
Phenotypic and chemotaxonomic identification. The isolate identified by the API Coryne system as Rhodococcus in the diagnostic laboratory of the treating hospital was sent to a reference laboratory for confirmation. This strain had a coccoid morphology in old cultures, resembling Rhodococcus, but branching rods were seen in young cultures (24 h) obtained from liquid media (see Fig. S4 in the supplemental material). After another 24 h, the rods started to fragment into smaller cells. The colony color on glucose-yeast extract agar was salmon pink and turned orange during cultivation. The strain was susceptible to amikacin, trimethoprim-sulfamethoxazole (TMP-SMX), amoxicillin-clavulanate, and linezolid, showed intermediate resistance to minocycline, imipenem, and moxifloxacin, and was resistant to ceftriaxone, clarithromycin, and ciprofloxacin by broth microdilution methodology, using interpretive criteria for Nocardia and other actinomycetes (9) (see Table S4 in the supplemental material).
The panel of chemotaxonomic tests was performed, and meso-DAP was detected in whole-cell hydrolysates, as were arabinose and galactose as diagnostic sugars. In addition, glucose and mannose were identified. N-Glycolylated muramic acid in peptidoglycan of the isolate was detected by the colorimetric method. The straight-chain saturated or monounsaturated fatty acids C16:0, C18:0, and C18:1, as well as tuberculostearic acid (10-methylbranched C18:0), were present. In the lipid extract, the diagnostic phospholipid phosphatidylethanolamine and major glycolipids were identified. Mycolic acid analysis of Nocardia asteroides, N. farcinica, and the clinical isolate by MALDI-TOF MS showed the same range of molecular ions, with heterogeneity of the chain lengths of mycolic acids (Fig. 3) . The calculated chain lengths of these nocardiomycolic acids ranged from 52 to 59 carbons, with the main peak belonging to mycolic acid, with a chain length of 55 carbon atoms and 4 double bonds (the observed value of the sodiated molecular ion was m/z 851.56, and the calculated value was m/z 851.81). The mycolic acid identification was crucial, as it classified the isolate as being in the Nocardia genus. Representatives of the Corynebacterineae suborder possess long-chain branched hydroxy acids of various chain lengths, which are characteristic for the genus; for Nocardia spp., the number of carbons is between 48 and 60 (21) . Based on chemotaxonomy, the clinical isolate was identified as Nocardia sp.
MALDI-TOF MS Biotyper identification.
The clinical strain was then identified by MALDI-TOF MS first using the Bruker Biotyper database. The direct smear method yielded poor spectra, and thus identification was not possible. The extraction procedure optimized for Nocardia (M2) was then used (Fig. 2f) . The identi- fication result was N. farcinica, with a score value of 1.63, which implied poor test reliability according to the manufacturer. The same sample checked with the Ultraflex mass spectrometer demonstrated an increased identification score of 1.72.
The final identification of the clinical strain using the optimal parameters and our in-house Corynebacterineae database is presented in Table 3 . The strain was identified as N. farcinica with a score of 2.27 or N. asteroides with a score of 2.12. Both values T (GenBank no. EU178747). On the basis of 16S rRNA and secA1 sequencing results, we concluded that the isolate should be assigned to N. farcinica. Phylogenetic analysis showed that the phylogenetic trees prepared for the 16S rRNA and secA1 genes by different methods had highly similar branches.
The clinical isolate strain was deposited in the Polish Collection of Microorganisms (N. farcinica PCM 2712).
DISCUSSION
Nocardia is a rare cause of intracranial abscesses, representing only 1% to 2% of all such lesions (22) , and is rarer still in immunocompetent patients (23) . However, the number of the case reports (25) (26) (27) (28) . Nearly onehalf of the cases involved primary brain abscesses. The studies by Wang et al. (29) of 132 nocardiosis patients with underlying cancer disease showed that N. farcinica was responsible for most of the brain and skin infections. The authors concluded that, in view of the isolation frequency, the invasiveness, and the lowest susceptibility to antimicrobials, N. farcinica is the most pathogenic of the Nocardia species (29) . The mortality rates for nocardial abscesses are higher than those for most other brain abscesses, being 55% in immunocompromised patients and 20% in immunocompetent patients (30, 31) .
Brain abscesses can mimic brain tumors in terms of both clinical presentation and diagnostic imaging results. Menkü et al. (23) reviewed 10 cases of primary nocardiosis in immunocompetent patients. In 6 cases, the lesions were initially diagnosed as neoplasms. The consequences of such misdiagnosis can be grave. Corticosteroids are routinely used with success to ameliorate peritumoral brain edema, but this treatment can lead to rapid progression when the lesion is of infectious etiology. In addition, early administration of empirical antibiotics can improve overall outcomes.
In the case described above, the clinical strain was susceptible to TMP-SMX, the drug of choice for the treatment of nocardiosis (32) . Appropriate identification and assessment of the antibiotic sensitivity pattern allow targeted therapy, which is of critical importance considering the high mortality rates. The mortality rates remain high with TMP-SMX monotherapy, especially for patients with CNS infections and other severe or disseminated cases. Stamm et al. (33) described a fatal case of an immunocompromised patient with Nocardia brasiliensis pneumonia and empyema that was refractory to therapy with sulfisoxazole, trimethoprim, and sulfamethoxazole and was complicated by disseminated infection with N. asteroides. Both Nocardia strains were susceptible to trimethoprim and sulfonamides in vitro. There are controversial reports concerning the susceptibility of Nocardia spp. to TMP-SMX. However, an in vitro multicenter study performed in the United States revealed that only 2% of 552 studied Nocardia clinical isolates were found to have resistance to TMP-SMX (34) . In cases of patients with allergy or intolerance to sulfonamides, alternative therapy should be introduced (32) . It appears that effective regimens for the treatment of nocardiosis should include linezolid (35, 36) .
The present work highlighted the difficulties encountered in Nocardia identification, i.e., (i) the early diagnosis based on MRI results suggested brain cancer, (ii) identification by the automated system as Rhodococcus sp. was incorrect, and (iii) identification at the species level was difficult. Even after using a standard extraction procedure and the MALDI Biotyper database, some additional work was required to improve the reliability of identification.
The results on urease and glucose fermentation obtained for the clinical isolate R679 in the API Coryne system were different from those found for N. farcinica (37) . Nocardia and Rhodococcus possess similar enzymatic activities in 20 tests detected in API ZYM profiles; the only difference between N. farcinica and R. rhodochrous was phosphohydrolase activity (38) . The API Coryne system is the most commonly used method and is well suited for identification of Corynebacterineae in routine laboratory practice, but it is not recommended for identification of aerobic actinomycetes, including Nocardia. Limitations of this system for identification in the Corynebacterium genus have been described elsewhere (39) . For acid-fast Gram-positive rods from the Rhodococcus, Gordonia, Tsukamurella, and Nocardia genera, the identification usefulness of the API Coryne system is limited (40) . In the present work, the chemotaxonomic analysis confirmed that the isolate belonged to the Corynebacterineae suborder, and the most useful mycolic acid analysis showed that the isolate was a member of the Nocardia genus.
The taxonomy of Nocardia is changing rapidly, mainly due to developments in the field of bacterial identification. At present, 104 validly published species of the Nocardia genus are listed at the LPSN (list of prokaryotic names with standing in nomenclature) website (http://www.bacterio.net/index.html). The phenotypic, chemotaxonomic, and genotyping methods used by researchers for the identification of Nocardia isolates are numerous (Table 4) . Historically, identification initially relied mostly on morphology and biochemical reactions. To this day, phenotypic methods for Nocardia identification are difficult, laborious, and time-consuming, often requiring batteries of tests before the final results are obtained. Advances in the automation of biochemical tests resulted in increased rates of processing. In order to increase test reliability, however, the existing databases must be improved to follow changes in taxonomy and the introduction of new species. Various molecular methods have been developed to improve the identification process (Table 4) . However, DNA sequencing methods are still expensive, labor-intensive, and unavailable in many laboratories. In the case of Nocardia spp., relative genome ambiguity renders the precision of 16S RNA gene identification insufficient. According to CLSI recommendation, 99.6% identity of 16S rRNA sequences is required for genus and species identification. For Nocardia, the alternative DNA target secA1 provides better resolution at the species level. Even the multilocus sequence typing technique using four genes does not provide adequate discriminating power to identify novel Nocardia species (41) . Proteomics-based methods are expected to be used more often in the future, due to much improved specificity and efficiency of mass spectroscopic techniques. MALDI-TOF mass spectrometry is an alternative to classical microbial and genetic identification techniques. This technique gives excellent results for Gram-negative bacteria even when the direct colony method is utilized. For characterization by MALDI-TOF MS, Nocardia spp., like Mycobacterium spp., require an additional extraction step before protein mass fingerprinting (7). This is due mainly to the thickness and strong hydrophobicity of the cell wall. We have noticed greater cell hydrophobicity in Nocardia than in Corynebacterium cells. The procedure is relatively fast, compared to molecular and phenotypic methods. The studies performed by Seng et al. (42) showed that MALDI-TOF MS reduced the identification times 55-fold and 169-fold and the costs 5-fold and 96-fold, compared with conventional phenotypic identification and gene sequencing, respectively.
In the case presented, the identification results obtained with the Biotyper MALDI-TOF system were correct (as corroborated by 16S rRNA and secA1 sequencing results), but the score value obtained afforded identification only to the genus level. The same approach was used in our case. Reliable identification of the clinical isolate was possible only after the generation of an in-house database, expanding the stock Bruker Biotyper database. To our surprise, the latter did not include the species N. asteroides, which, for many years before genotypic methods were introduced, was thought to be the most common agent of nocardiosis (see Table S5 in the supplemental material). Currently, nocardiae from the former N. asteroides complex, i.e., N. farcinica and Nocardia cyriacigeorgica, are responsible for most nocardiosis cases; the incidences of these two strains vary geographically. Therefore, the creation of an in-house database for the reference Nocardia, Corynebacterium, Gordonia, Rhodococcus, Mycobacterium, and Tsukamurella species was mandatory. Our database contains 6 species not represented in the Biotyper database, namely, Gordonia amarae, N. asteroides, Nocardia mikamii, M. scrofulaceum, Tsukamurella pulmonis, and Tsukamurella tyrosinosolvens. The Bruker Biotyper database used in this study (DB 4613) contains 70 different Corynebacterium species, 7 Gordonia species, 42 Mycobacterium species, 32 Nocardia species, 27 Rhodococcus species, and two Tsukamurella species. The optimal conditions were selected to acquire the best MALDI-TOF spectra that were least affected by the cultivation conditions, were reproducible, and were unique for a given bacterial strain.
We can conclude that, by upgrading commercial databases, it is possible to accelerate and to improve the accuracy of strain identification. This is especially important in the case of Nocardia, for which valid microbial diagnosis remains challenging; reference laboratories are often required to identify and to survey these rare actinobacteria.
